Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rouxel RN"'
Autor:
Bouzya B; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Rouxel RN; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium.; MSD Animal Health, Thormøhlensgate 55, 5006, Bergen, Norway., Sacconnay L; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Mascolo R; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Nols L; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Quique S; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., François L; Akkodis, Belgium c/o GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Atas A; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Warter L; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Dezutter N; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium., Lorin C; GSK, Rue de l'Institut 89, 1330, Rixensart, Belgium. clarisse.m.lorin@gsk.com.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2023 Sep 29; Vol. 8 (1), pp. 143. Date of Electronic Publication: 2023 Sep 29.
Autor:
Folschweiller N; GSK, Wavre, Belgium; Takeda Pharmaceuticals, Zurich, Switzerland. Electronic address: nicolas.folschweiller@takeda.com., Vanden Abeele C; GSK, Wavre, Belgium., Chu L; Benchmark Research, Austin, TX, USA., Van Damme P; University of Antwerp, Centre for the Evaluation of Vaccination, Antwerp, Belgium., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Moderna, Cambridge, MA, USA., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Solórzano A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Pfizer, Pearl River, NY, USA., Bi D; GSK, Wavre, Belgium., David MP; GSK, Wavre, Belgium., Friel D; GSK, Wavre, Belgium., Innis BL; GSK, King of Prussia, PA, USA; PATH, Washington, DC, USA., Koch J; GSK, Wavre, Belgium; UCB, Brussels, Belgium., Mallett CP; GSK, Rockville, MD, USA., Rouxel RN; GSK, Rixensart, Belgium; MSD Animal Health, Bergen, Norway., Salaun B; GSK, Rixensart, Belgium., Vantomme V; GSK, Wavre, Belgium., Verheust C; GSK, Wavre, Belgium., Struyf F; GSK, Wavre, Belgium; Janssen Research and Development, Beerse, Belgium.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jul; Vol. 22 (7), pp. 1062-1075. Date of Electronic Publication: 2022 Apr 21.
Autor:
Destexhe É; GSK, Rixensart, Belgium. Electronic address: eric.x.destexhe@gsk.com., Grosdidier É; Charles River Laboratories Évreux, France., Bouhraoua A; Charles River Laboratories Évreux, France., Thirion-Delalande C; Charles River Laboratories Évreux, France., Bouzya B; GSK, Rixensart, Belgium., Rouxel RN; GSK, Rixensart, Belgium., Mallett CP; GSK, Rockville, MD, USA., Baumeister J; GSK, Wavre, Belgium.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2020 Jun; Vol. 113, pp. 104625. Date of Electronic Publication: 2020 Feb 28.
Autor:
Nachbagauer R; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Salaun B; 2GSK, Rixensart, Belgium., Stadlbauer D; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Behzadi MA; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Friel D; 3GSK, Wavre, Belgium., Rajabhathor A; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Choi A; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 4Graduate School of Biomedical Services, Icahn School of Medicine at Mount Sinai, New York, NY USA., Albrecht RA; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 5Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA., Debois M; 3GSK, Wavre, Belgium., García-Sastre A; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 5Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 6Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA., Rouxel RN; 2GSK, Rixensart, Belgium., Sun W; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Palese P; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 6Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA., Mallett CP; 7GSK, Rockville, MD 20850 USA., Innis BL; 8GSK, King of Prussia, PA USA.; 10Present Address: PATH, Washington, DC, USA., Krammer F; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Claeys C; 9GSK, Rixensart, Belgium.; Present Address: Spmt-Arista Asbl, Brussel, Belgium.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2019 Dec 06; Vol. 4, pp. 51. Date of Electronic Publication: 2019 Dec 06 (Print Publication: 2019).
Autor:
Choi A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Bouzya B; GlaxoSmithKline, 1330 Rixensart, Belgium., Cortés Franco KD; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Stadlbauer D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Rajabhathor A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Rouxel RN; GlaxoSmithKline, 1330 Rixensart, Belgium., Mainil R; GlaxoSmithKline, 1330 Rixensart, Belgium., Van der Wielen M; GlaxoSmithKline, 1300 Wavre, Belgium., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and., Innis BL; GlaxoSmithKline, Rockville, MD 20850., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Schotsaert M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029., Mallett CP; GlaxoSmithKline, Rockville, MD 20850 raffael.nachbagauer@mssm.edu corey.p.mallett@gsk.com., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; raffael.nachbagauer@mssm.edu corey.p.mallett@gsk.com.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2019 Apr 01; Vol. 3 (4), pp. 133-148.
Autor:
Rouxel RN; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas, France., Tafalla C; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas, France.; Animal Health Research Center (CISA-INIA), Valdeolmos, Madrid, Spain., Mérour E; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas, France., Leal E; Animal Health Research Center (CISA-INIA), Valdeolmos, Madrid, Spain., Biacchesi S; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas, France., Brémont M; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas, France michel.bremont@jouy.inra.fr.
Publikováno v:
Journal of virology [J Virol] 2016 Nov 14; Vol. 90 (23), pp. 10857-10866. Date of Electronic Publication: 2016 Nov 14 (Print Publication: 2016).
Autor:
Rouxel RN; VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France., Mérour E; VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France., Biacchesi S; VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France., Brémont M; VIM, INRA, Université Paris-Saclay, 78350, Jouy-en-Josas, France.
Publikováno v:
PloS one [PLoS One] 2016 Oct 06; Vol. 11 (10), pp. e0164245. Date of Electronic Publication: 2016 Oct 06 (Print Publication: 2016).
Autor:
Mazelier M; CellNetworks Cluster of Excellence and Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany., Rouxel RN; INRS-Institut Armand-Frappier, Université du Québec, Laval, Canada., Zumstein M; ETH Zurich, Institute of Biochemistry, Zurich, Switzerland., Mancini R; ETH Zurich, Institute of Biochemistry, Zurich, Switzerland., Bell-Sakyi L; The Pirbright Institute, Pirbright, United Kingdom., Lozach PY; CellNetworks Cluster of Excellence and Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany INRS-Institut Armand-Frappier, Université du Québec, Laval, Canada ETH Zurich, Institute of Biochemistry, Zurich, Switzerland pierre-yves.lozach@med.uni-heidelberg.de.
Publikováno v:
Journal of virology [J Virol] 2016 Jul 11; Vol. 90 (15), pp. 6784-98. Date of Electronic Publication: 2016 Jul 11 (Print Publication: 2016).
Autor:
Léger P; CellNetworks - Cluster of Excellence and Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany., Tetard M; INRS-Institut Armand-Frappier, Laval, Canada.; Current address: Inserm UMR_S1134, Paris, France., Youness B; CellNetworks - Cluster of Excellence and Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany.; INRS-Institut Armand-Frappier, Laval, Canada.; Reproduction Genetics Unit, Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital, Heidelberg, Germany., Cordes N; CellNetworks - Cluster of Excellence and Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany., Rouxel RN; INRS-Institut Armand-Frappier, Laval, Canada.; UR_0892 Unité de Virologie et Immunologie Moléculaire, INRA, CRJ, Jouy-en-Josas, France., Flamand M; Structural Virology, Institut Pasteur, Paris, France., Lozach PY; CellNetworks - Cluster of Excellence and Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany.; INRS-Institut Armand-Frappier, Laval, Canada.
Publikováno v:
Traffic (Copenhagen, Denmark) [Traffic] 2016 Jun; Vol. 17 (6), pp. 639-56. Date of Electronic Publication: 2016 Apr 21.
Autor:
Rouxel RN; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France. ronan.rouxel@jouy.inra.fr., Mérour E; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France. emilie.merour@jouy.inra.fr., Biacchesi S; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France. stephane.biacchesi@jouy.inra.fr., Brémont M; VIM, INRA, Université Paris-Saclay, Jouy-en-Josas 78350, France. michel.bremont@jouy.inra.fr.
Publikováno v:
Viruses [Viruses] 2016 Mar 04; Vol. 8 (3), pp. 69. Date of Electronic Publication: 2016 Mar 04.